Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Modular Medical, Inc. (MODD : NSDQ)
 
 • Company Description   
Modular Medical Inc. is a development-stage company in the diabetes/insulin delivery space. Modular Medical Inc. is based in SAN DIEGO, CA.

Number of Employees: 54

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.46 Daily Weekly Monthly
20 Day Moving Average: 26,812 shares
Shares Outstanding: 4.66 (millions)
Market Capitalization: $16.13 (millions)
Beta: 0.24
52 Week High: $30.60
52 Week Low: $3.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.22% -32.62%
12 Week -77.37% -79.30%
Year To Date -68.36% -71.12%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10470 Thornmint Road
-
SAN DIEGO,CA 92127
USA
ph: 858-800-3500
fax: -
info@modular-medical.com http://www.modularmedical.com
 
 • General Corporate Information   
Officers
James E. Besser - Chief Executive Officer
Paul DiPerna - Chairman; President and Chief Financial Officer
Duane DeSisto - Director
Steven Felsher - Director
Morgan C. Frank - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 60785L306
SIC: 3841
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 06/19/26
Share - Related Items
Shares Outstanding: 4.66
Most Recent Split Date: 3.00 (0.03:1)
Beta: 0.24
Market Capitalization: $16.13 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 06/19/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.52
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 15.38%
vs. Previous Quarter: 21.43%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/26 - -
12/31/25 - -245.85
09/30/25 - -202.07
ROA
03/31/26 - -
12/31/25 - -190.80
09/30/25 - -166.97
Current Ratio
03/31/26 - -
12/31/25 - 1.59
09/30/25 - 1.47
Quick Ratio
03/31/26 - -
12/31/25 - 1.59
09/30/25 - 1.47
Operating Margin
03/31/26 - -
12/31/25 - -
09/30/25 - -
Net Margin
03/31/26 - -
12/31/25 - -
09/30/25 - -
Pre-Tax Margin
03/31/26 - -
12/31/25 - -
09/30/25 - -
Book Value
03/31/26 - -
12/31/25 - 2.27
09/30/25 - 4.76
Inventory Turnover
03/31/26 - -
12/31/25 - -
09/30/25 - -
Debt-to-Equity
03/31/26 - -
12/31/25 - 0.00
09/30/25 - 0.00
Debt-to-Capital
03/31/26 - -
12/31/25 - 0.00
09/30/25 - 0.00
 

Powered by Zacks Investment Research ©